New technology can create treatment against drug-resistant bacteria, adapt to antibiotic resistance
泭
泭泭The Conversation
is an independent, nonprofit publisher of commentary and analysis, authored by academics and edited by journalists for the general public. On泭a mission to promote truthful information and strengthen journalism by unlocking the rich diversity of academic research for audiences across America, they泭publish short articles泭by academics on timely topics related to their research. CU 勒貊勛圖 provides funding as a member of The Conversation U.S.
Antibiotic resistance is one of the biggest public health threats in the world. New research, however, may have found a way to keep up with rapidly evolving bacteria. PhD candidate Kristen Eller shares on The Conversation.
泭
Categories: The Conversation
泭